Concentrix Corporation (CNXC)
Concentrix Statistics
Share Statistics
Concentrix has 63.88M shares outstanding. The number of shares has increased by -2.51% in one year.
Shares Outstanding | 63.88M |
Shares Change (YoY) | -2.51% |
Shares Change (QoQ) | -0.74% |
Owned by Institutions (%) | 89.08% |
Shares Floating | 45.26M |
Failed to Deliver (FTD) Shares | 15 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 7.31M, so 11.45% of the outstanding shares have been sold short.
Short Interest | 7.31M |
Short % of Shares Out | 11.45% |
Short % of Float | 13.74% |
Short Ratio (days to cover) | 4.86 |
Valuation Ratios
The PE ratio is 11.63 and the forward PE ratio is 4.04. Concentrix's PEG ratio is -0.33.
PE Ratio | 11.63 |
Forward PE | 4.04 |
PS Ratio | 0.3 |
Forward PS | 0.3 |
PB Ratio | 0.72 |
P/FCF Ratio | 6.81 |
PEG Ratio | -0.33 |
Enterprise Valuation
Concentrix has an Enterprise Value (EV) of 7.42B.
EV / Sales | 0.77 |
EV / EBITDA | 12.43 |
EV / EBIT | 11.11 |
EV / FCF | 17.3 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 1.17.
Current Ratio | 1.42 |
Quick Ratio | 1.42 |
Debt / Equity | 1.17 |
Debt / EBITDA | 7.94 |
Debt / FCF | 11.05 |
Interest Coverage | 1.85 |
Financial Efficiency
Return on Equity is 6.22% and Return on Invested Capital is 5.01%.
Return on Equity | 6.22% |
Return on Assets | 2.09% |
Return on Invested Capital | 5.01% |
Revenue Per Employee | $21.38K |
Profits Per Employee | $558.26 |
Employee Count | 450,000 |
Asset Turnover | 0.8 |
Inventory Turnover | n/a |
Taxes
Income Tax | 48.06M |
Effective Tax Rate | 16.06% |
Stock Price Statistics
The stock price has increased by -8.69% in the last 52 weeks. The beta is 0.57, so Concentrix's price volatility has been higher than the market average.
Beta | 0.57 |
52-Week Price Change | -8.69% |
50-Day Moving Average | 47.66 |
200-Day Moving Average | 52.48 |
Relative Strength Index (RSI) | 53.56 |
Average Volume (20 Days) | 949.88K |
Income Statement
In the last 12 months, Concentrix had revenue of 9.62B and earned 251.22M in profits. Earnings per share was 3.72.
Revenue | 9.62B |
Gross Profit | 3.45B |
Operating Income | 596.39M |
Net Income | 251.22M |
EBITDA | 596.39M |
EBIT | 621.1M |
Earnings Per Share (EPS) | 3.72 |
Balance Sheet
The company has 240.57M in cash and 4.74B in debt, giving a net cash position of -4.5B.
Cash & Cash Equivalents | 240.57M |
Total Debt | 4.74B |
Net Cash | -4.5B |
Retained Earnings | 1.19B |
Total Assets | 11.9B |
Working Capital | 1.17B |
Cash Flow
In the last 12 months, operating cash flow was 667.49M and capital expenditures -238.76M, giving a free cash flow of 428.73M.
Operating Cash Flow | 667.49M |
Capital Expenditures | -238.76M |
Free Cash Flow | 428.73M |
FCF Per Share | 6.6 |
Margins
Gross margin is 35.86%, with operating and profit margins of 6.2% and 2.61%.
Gross Margin | 35.86% |
Operating Margin | 6.2% |
Pretax Margin | 3.11% |
Profit Margin | 2.61% |
EBITDA Margin | 6.2% |
EBIT Margin | 6.2% |
FCF Margin | 4.46% |
Dividends & Yields
CNXC pays an annual dividend of $1.6, which amounts to a dividend yield of 2.55%.
Dividend Per Share | $1.60 |
Dividend Yield | 2.55% |
Dividend Growth (YoY) | 10% |
Payout Ratio | 41.53% |
Earnings Yield | 8.6% |
FCF Yield | 14.68% |
Analyst Forecast
The average price target for CNXC is $70, which is 39.4% higher than the current price. The consensus rating is "Buy".
Price Target | $70 |
Price Target Difference | 39.4% |
Analyst Consensus | Buy |
Analyst Count | 5 |
Scores
Altman Z-Score | 1.49 |
Piotroski F-Score | 8 |